Katsushi Shibata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Katsushi Shibata has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Hiroyuki Ozawa
Department of Otolaryngology, Head and Neck Surgery, Keio University School of Medicine, Tokyo 160‑8582, Japan
1 shared publication - Kaori Kameyama
Keio University Hospital
1 shared publication - Kaoru Ogawa
Keio University School of Medicine
1 shared publication - Koji Sakamoto
Department of Otorhinolaryngology, Saiseikai Utsunomiya Hospital, Utsunomiya, Japan
1 shared publication - Kuninori Otsuka
Department of Otorhinolaryngology, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Kanagawa, 230-8765, Japan
1 shared publication - Masato Fujii
National Institute of Sensory Organs, National Tokyo Medical Center, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 10 May 2014
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 33 (1) , 40
Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma
The epithelial-to-mesenchymal transition (EMT) accompanied by the downregulation of E-cadherin has been thought to promote metastasis. Cyclooxygenase-2 (Cox-2) is presumed to contribute to cancer progression through its multifaceted function, and recently its inverse relationship with E-cadherin was suggested. The aim of the present study was to investigate whether selective Cox-2 inhibitors restore the expression of E-cadherin in head and neck squamous cell carcinoma (HNSCC) cells, and to examine the possible correlations of the expression levels of EMT-related molecules with clinicopathological factors in HNSCC.
- 10 May 2014
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 33 (1) , 40
Open AccessRestoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma
The epithelial-to-mesenchymal transition (EMT) accompanied by the downregulation of E-cadherin has been thought to promote metastasis. Cyclooxygenase-2 (Cox-2) is presumed to contribute to cancer progression through its multifaceted function, and recently its inverse relationship with E-cadherin was suggested. The aim of the present study was to investigate whether selective Cox-2 inhibitors restore the expression of E-cadherin in head and neck squamous cell carcinoma (HNSCC) cells, and to examine the possible correlations of the expression levels of EMT-related molecules with clinicopathological factors in HNSCC.